Clinical validation of pharmacokinetic/pharmacodynamic models for propofol infusion. Response to Br J Anaesth 2021: 126: e172-4
Authors:
- 1 July 2021
- journal article
- editorial
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 127 (1) , e3-e5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical validation of pharmacokinetic and pharmacodynamic models for propofol infusion. Comment on Br J Anaesth 2021; 126: 386–94British Journal of Anaesthesia, 2021
- Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesiaBritish Journal of Anaesthesia, 2021
- The Drug Titration Paradox: Correlation of More Drug With Less Effect in Clinical DataClinical Pharmacology & Therapeutics, 2021
- Do Vancomycin Pharmacokinetics Differ Between Obese and Non-obese Patients? Comparison of a General-Purpose and Four Obesity-Specific Pharmacokinetic ModelsTherapeutic Drug Monitoring, 2020
- Relationship Between Propofol Target Concentrations, Bispectral Index, and Patient Covariates During AnesthesiaAnesthesia & Analgesia, 2020
- Target‐controlled‐infusion for special populations: How different is different enough?Acta Anaesthesiologica Scandinavica, 2019
- An Intellectual Framework for Drug Administration Methods in Anesthesia: Three Practice DomainsAnesthesia & Analgesia, 2018
- Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesiaBritish Journal of Anaesthesia, 2018
- Pharmacokinetic–pharmacodynamic model for propofol for broad application in anaesthesia and sedationBritish Journal of Anaesthesia, 2018
- Measuring the predictive performance of computer-controlled infusion pumpsJournal of Pharmacokinetics and Biopharmaceutics, 1992